The Scientist

Bridge RNA as a Promising Genome Editing Platform

Researchers reprogrammed bacterial bridge recombinases to edit large genomic regions in mammalian cells, revealing a ...
BioSpace

Wave To Work Alone on RNA Editor as AATD Picture Becomes Clearer

After GSK’s return of Wave Life Sciences’ WVE-006 as well as the mid-stage failure of Korro Bio’s candidate, the alpha-1 ...
Hosted on MSN

Editing Parkinson's disease—discovery of an inflammatory RNA editing enzyme

Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, ...
EurekAlert!

Small nuclear RNA base editing a safer alternative to CRISPR, UC San Diego researchers find

Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale ...
Nasdaq

ProQR Therapeutics Advances Axiomer RNA Editing Pipeline with Leadership Appointments and Strong Financial Position

ProQR Therapeutics advances RNA editing pipeline with upcoming CTA filing for AX-0810, while enhancing leadership and maintaining strong finances. ProQR Therapeutics N.V. announced significant ...
EurekAlert!

Editing Parkinson's Disease – KAIST makes world's first discovery of an inflammatory RNA editing enzyme

Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, ...